Skip to content

Barostat Software Option

by Crospon, Ltd.

510(k) K120997

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK120997 Date27 Aug 2012ClearedStatusActive

Official records

From the FDA record

Received by the FDA
2 Apr 2012
FDA decision
27 Aug 2012 (Substantially Equivalent)
FDA review time
147 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K120997 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
FFX
Device class
Class II
Regulation
21 CFR Part 876.1725
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Barostat Software Option is a software enhancement for a gastrointestinal motility monitoring system, classified as a System, Gastrointestinal Motility (Electrical). It enables programmed balloon inflation in incremental volume steps (0–50 ml) via a catheter-based system with 16 electrodes, measuring intraluminal pressure and dimensions within the esophagus. This modality supports functional assessment of esophageal motility and pressure dynamics, aligning with the predicate device’s intended use for diagnostic gastrointestinal studies.

This software option is supplied as part of a larger system and is intended for use in clinical settings such as hospitals and physician offices. It is not described as single-use or reusable in the regulatory data, nor are MRI safety or sterility specifications provided. The device holds an FDA 510(k) clearance (K120997) under the Traditional review pathway, with a classification of Class II (FFX product code). No additional regulatory markings or storage conditions are specified beyond those inherent to its system integration.

Devices cleared under K120997

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K120997
UDI-DISize and differences
EndoFLIP EF-322
Crospon, Ltd.
EF-32205391530810029 —On the market

Similar devices

Other devices filed under FDA product code FFX (System, Gastrointestinal Motility (Electrical)).

Other devices from Crospon, Ltd.

See all devices from Crospon, Ltd. →